title: Factor VIII safety: plasma-derived versus recombinant products.
authors.affiliation: Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Department of Medicine and Medical Specialities, IRCCS Ca' Granda Foundation, Maggiore Policlinico Hospital and University of Milan, Milan, Italy. alessandro.gringeri@unimi.it
authors.forename: Alessandro
authors.initials: A
authors.lastname: Gringeri
mesh_terms: D005169:Factor VIII / Q000302:isolation & purification / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D010949:Plasma / Q000737:chemistry; D011994:Recombinant Proteins / Q000627:therapeutic use; D012449:Safety
chemical_list: D011994:Recombinant Proteins; D005169:Factor VIII